首页> 外国专利> MEDICAL USE OF TWITTERION COMPOUNDS AS MODULATORS OF THE CFTR CHANNEL

MEDICAL USE OF TWITTERION COMPOUNDS AS MODULATORS OF THE CFTR CHANNEL

机译:三聚体化合物作为CFTR通道调节剂的医学用途

摘要

Composition comprises a compound (I) that forms a zwitterion (II) at physiological pH. Composition comprises a compound (I) that forms a zwitterion of formula (II) at physiological pH. [Image] Independent claims are also included for: (1) zwitterionic 4,5-dihydroxy-3,4,5,6-tetrahydropyrimidine-6-carboxylic acid derivatives of formula (IA), produced by reacting an amidine of formula H 2N-CR 1=NR 2with a glyoxal compound of formula R 3-CO-CHO and R 4-CO-CHO, provided that the amidine is not 2-aminopyridine, adenine, adenosine, 2'-deoxyadenosine, 9-propyladenine, cytosine, polyadenylic acid, arginine or their derivatives when methylglyoxal is used; (2) zwitterionic pyrimidine derivatives of formula (IB), and (3) preparation of (IB). [Image] R 1-R 4optionally substituted cyclic or acyclic carbon chain optionally containing heteroatoms, and Z : O or S. ACTIVITY : Antidiarrheic; Respiratory-Gen.; Antiasthmatic. MECHANISM OF ACTION : Cystic fibrosis transmembrane conductance regulator (CFTR) channel modulator. In a test, the adduct of 2'-deoxyadenosine and methylglyoxal exhibited an IC 50value of 70.8 pM against forskoline-induced activation of CFTR receptor in transfected Chinese hamster ovary cells.
机译:组合物包含在生理pH下形成两性离子(II)的化合物(I)。组合物包含在生理pH下形成式(II)的两性离子的化合物(I)。 [图像]还包括以下方面的独立权利要求:(1)通过使式H 2N的react反应制备的式(IA)的两性离子的4,5-二羟基-3,4,5,6-四氢嘧啶-6-羧酸衍生物-CR 1 = NR 2与式R 3-CO-CHO和R 4-CO-CHO的乙二醛化合物,条件是the不是2-氨基吡啶,腺嘌呤,腺苷,2'-脱氧腺苷,9-丙基腺嘌呤,胞嘧啶,当使用甲基乙二醛时,聚腺苷酸,精氨酸或其衍生物; (2)式(IB)的两性离子嘧啶衍生物,和(3)(IB)的制备。 [图像] R 1 -R 4任选取代的环状或无环碳链,任选包含杂原子,Z:O或S。呼吸器;抗哮喘。作用机理:囊性纤维化跨膜电导调节剂(CFTR)通道调节剂。在一项测试中,针对福斯科林诱导的中国仓鼠卵巢细胞中CFTR受体的激活,2'-脱氧腺苷和甲基乙二醛的加合物显示出IC 50值为70.8 pM。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号